Posted by Michael Wonder on 11 Nov 2019
More than ever, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do it.
11 November 2019 - President Trump has made drug pricing a key policy tenet of his three-year tenure in the White House. And as his drug pricing policy has grown more aggressive in the past year, his Democratic challengers in the 2020 election have responded in kind.
The increasingly aggressive Democratic platform follows roughly a decade of stagnation. Since the mid-2000s, Democratic lawmakers have focused far more on expanding access to health insurance than they have on prescription drug policy.
This cycle, Democratic policy aimed at lowering drug costs has focused on three distinct areas: allowing direct Medicare negotiation; allowing importation of prescription drugs from other developed countries, namely Canada; and fostering generic drug competition.
